Publications by authors named "A A al-Ruhaily"
Background: To determine causes of short stature (SS) in adult endocrine service at a Saudi Arabian tertiary center.
Methods: A retrospective analysis was made of data from 104 subjects who were primarily evaluated for causes of SS in the endocrinology unit of King Khalid University Hospital Riyadh from January 1 997 to December 2006.
Results: Growth hormone deficiency (GHD) and normal variant short stature (NVSS) were the leading causes of SS contributing 90 subjects (86%; 43% for each), followed by celiac disease in 4 subjects (4%).
Objective: To determine clinical manifestation and mode of treatment of Graves' disease at King Khalid University Hospital Riyadh, Saudi Arabia.
Methods: A retrospective study of all cases of Graves' disease diagnosed at the hospital in the period between January 1995 and December 2004, who received a minimum of two years treatment were included in the study.
Results: A total of 194 patients were seen with female: male ratio of 2.
Background: Short stature (SS) can be treatable; yet the diagnostic value of a simple test in correctly identifying the two common etiologies in developing countries, viz., growth hormone deficiency (GHD) and normal variant short stature (NVSS), has not been reported in a typical third world population.
Objectives: The aim of the study was to evaluate the reliability of clonidine test in differentiating short stature caused by GHD from NVSS.
Background: Hirsutism among women of fertile age is commonly seen in clinical practice, but the pattern of the disease in Saudi Arabs has not been studied. The aim of the study was to determine the clinical, biochemical and etiologic features of hirsutism in Saudi females.
Methods: 101 Saudi Arab women presenting with hirsutism at King Khalid University Hospital, Riyadh, Saudi Arabia, from 1 January 2000 to 31 December 2005 were prospectively assessed using the recently approved diagnostic guidelines for hyperandrogenic women with hirsutism.
Objective: To determine whether clinical and biochemical features of Graves' disease at presentation predict response to medical and radioiodine treatment.
Methods: We carried out a retrospective 10-year study of 194 consecutive Saudi subjects with Graves' disease who were treated with antithyroid drugs, radioiodine therapy, or both, between January 1995 and December 2004 at King Khalid University Hospital, Riyadh, Saudi Arabia.
Results: At diagnosis, the mean age was 32 +/- 0.